# Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (P07015)

> **NCT00702806** · PHASE2 · COMPLETED · sponsor: **Organon and Co** · enrollment: 99 (actual)

## Conditions studied

- Infertility
- In Vitro Fertilization

## Interventions

- **DRUG:** Org 36286
- **DRUG:** Puregon®
- **DRUG:** Orgalutran®
- **DRUG:** Pregnyl®

## Key facts

- **NCT ID:** NCT00702806
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-07-01
- **Primary completion:** 2002-10-15
- **Final completion:** 2002-10-15
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00702806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00702806, "Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (P07015)". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00702806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*